miRNA and long non-coding RNA: molecular function and clinical value in breast and ovarian cancers

K Panoutsopoulou, M Avgeris… - Expert review of molecular …, 2018 - Taylor & Francis
target of the abovementioned miRNAs, and thus, their reduced levels in ovarian tumors
and improvements in disease management, breast and ovarian carcinomas remain highly …

MicroRNA-136 inhibits cancer stem cell activity and enhances the anti-tumor effect of paclitaxel against chemoresistant ovarian cancer cells by targeting Notch3

JY Jeong, H Kang, TH Kim, G Kim, JH Heo, AY Kwon… - Cancer letters, 2017 - Elsevier
… resensitized paclitaxel-resistant ovarian cancer cells and reduced … target for the treatment
of chemoresistant ovarian cancers. … miRNA prediction software to search for miRNAs targeting

The role of microRNAs in epithelial ovarian cancer metastasis

VHL Nguyen, C Yue, KY Du, M Salem… - International journal of …, 2020 - mdpi.com
Ovarian cancer is the fifth leading cause of cancer-related deaths in females [1]. Based on the
cell origin where ovarian tumors arise, ovarian cancer is … targets for cancer treatment [314]. …

[HTML][HTML] Regulation of metastasis by microRNAs in ovarian cancer

Y Wang, S Kim, I Kim - Frontiers in Oncology, 2014 - frontiersin.org
… of miR-214 targeted P53/Nanog axis and contributed to ovarian CSC … Ovarian cancer is
the most fatal gynecologic malignancy among women in the Unites States. Current treatment is …

Advances in ovarian cancer treatment beyond PARP inhibitors

F Aliyuda, M Moschetta, A Ghose… - … Cancer Drug Targets, 2023 - ingentaconnect.com
MicroRNAs have also become novel biomarkers for the therapy and clinical … the targeting
of growth-dependent pathways in ovarian cancer and assesses current data related to targeted

[HTML][HTML] MicroRNA-365 inhibits ovarian cancer progression by targeting Wnt5a

Y Wang, C Xu, Y Wang, X Zhang - American journal of cancer …, 2017 - ncbi.nlm.nih.gov
… candidate for therapeutic application in ovarian cancer treatment. … in ovarian cancer tissues
and adjacent ovarian cancer tissues by qRT-PCR. As shown in Figure 5A, ovarian cancer

MicroRNA let-7a: a potential marker for selection of paclitaxel in ovarian cancer management

L Lu, P Schwartz, L Scarampi, T Rutherford… - Gynecologic …, 2011 - Elsevier
cancer cells to platinum, but induce ovarian cancer resistance to paclitaxel. This study aims
to investigate the effect of let-7a expression on survival outcomes of epithelial ovarian cancer

Circulating biomarkers for detection of ovarian cancer and predicting cancer outcomes

I Shapira, M Oswald, J Lovecchio, H Khalili… - … journal of cancer, 2014 - nature.com
… available treatment for serous epithelial ovarian cancer from … utility of circulating miRNAs as
biomarkers in ovarian cancer, we … in gene targets/pathways of these three miRNAs to explain …

The emerging roles of miRNA-mediated autophagy in ovarian cancer

Y Ding, X Huang, T Ji, C Qi, X Gao, R Wei - Cell Death & Disease, 2024 - nature.com
ovarian cancer progression. This review focuses on the potential significance of miRNA-regulated
autophagy in the diagnosis and treatment … as another miRNA target. In hepatocellular …

MicroRNAs in ovarian cancer and recent advances in the development of microRNA-based biosensors

NB Aziz, RG Mahmudunnabi, M Umer, S Sharma… - Analyst, 2020 - pubs.rsc.org
… To address this issue, Wang et al. delineated a solution where miRNA target initiated the …
changes in ovarian cancer management strategies, by enabling low cost near-patient …